2011 annual financial data
Karyopharm Therapeutics 2011 Operating margin
Karyopharm Therapeutics 2011 operating margin with verified reported values.
Direct answer
Operating margin was -6,783.55%.
Operating income was -10,311,000 USD and net income was -10,311,000 USD.
Operating cash flow was -8,549,000 USD.
Get free Karyopharm Therapeutics email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 152,000 USD
- Operating income
- -10,311,000 USD
- Net income
- -10,311,000 USD
- Operating cash flow
- -8,549,000 USD